CH679207A5 - - Google Patents

Download PDF

Info

Publication number
CH679207A5
CH679207A5 CH2829/89A CH282989A CH679207A5 CH 679207 A5 CH679207 A5 CH 679207A5 CH 2829/89 A CH2829/89 A CH 2829/89A CH 282989 A CH282989 A CH 282989A CH 679207 A5 CH679207 A5 CH 679207A5
Authority
CH
Switzerland
Prior art keywords
trp
microparticles
tyr
copolymer
leu
Prior art date
Application number
CH2829/89A
Other languages
English (en)
French (fr)
Inventor
Piero Orsolini
Original Assignee
Debiopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm Sa filed Critical Debiopharm Sa
Priority to CH2829/89A priority Critical patent/CH679207A5/fr
Priority to IE259290A priority patent/IE65397B1/en
Priority to GB9015722A priority patent/GB2234169B/en
Priority to IL9512090A priority patent/IL95120A/en
Priority to BE9000729A priority patent/BE1003093A3/fr
Priority to AU59103/90A priority patent/AU619996B2/en
Priority to ZA905654A priority patent/ZA905654B/xx
Priority to NL9001646A priority patent/NL194858C/nl
Priority to FI903643A priority patent/FI97688C/fi
Priority to FR909009333A priority patent/FR2650182B1/fr
Priority to US07/555,973 priority patent/US5134122A/en
Priority to DE4023134A priority patent/DE4023134C2/de
Priority to ES9001976A priority patent/ES2020890A6/es
Priority to IT02101990A priority patent/IT1243357B/it
Priority to CA002021767A priority patent/CA2021767C/en
Priority to NO903264A priority patent/NO300304B1/no
Priority to AT0154590A priority patent/AT397197B/de
Priority to LU87772A priority patent/LU87772A1/fr
Priority to GR900100568A priority patent/GR1001215B/el
Priority to DK199001807A priority patent/DK175495B1/da
Priority to PT94842A priority patent/PT94842B/pt
Priority to JP2201063A priority patent/JPH0662427B2/ja
Priority to SE9002522A priority patent/SE504279C2/sv
Priority to US07/790,033 priority patent/US5439688A/en
Publication of CH679207A5 publication Critical patent/CH679207A5/fr
Priority to US07/836,478 priority patent/US5225205A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH2829/89A 1989-07-28 1989-07-28 CH679207A5 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)

Priority Applications (25)

Application Number Priority Date Filing Date Title
CH2829/89A CH679207A5 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) 1989-07-28 1989-07-28
IE259290A IE65397B1 (en) 1989-07-28 1990-07-16 A method for preparing a sustained-release pharmaceutical peptide composition
GB9015722A GB2234169B (en) 1989-07-28 1990-07-17 A method for preparing a sustained-release pharmaceutical peptide composition
IL9512090A IL95120A (en) 1989-07-28 1990-07-18 Preparation of sustained release pharmaceutical compositions comprising peptide salts, in the form of microparticles
BE9000729A BE1003093A3 (fr) 1989-07-28 1990-07-18 Procede de preparation d'une composition pharmaceutique sous forme de microparticules.
AU59103/90A AU619996B2 (en) 1989-07-28 1990-07-18 A method for preparing a pharmaceutical composition in the form of microparticles
ZA905654A ZA905654B (en) 1989-07-28 1990-07-18 A method for preparing a pharmaceutical composition in the form of microparticles
NL9001646A NL194858C (nl) 1989-07-28 1990-07-19 Werkwijze voor de bereiding van een farmaceutisch preparaat in de vorm van microdeeltjes, en een werkwijze voor de bereiding van farmaceutisch preparaat in de vorm van een injecteerbare suspentie van microdeeltjes.
FI903643A FI97688C (fi) 1989-07-28 1990-07-19 Menetelmä mikrohiukkasten muodossa olevan farmaseuttisen koostumuksen valmistamiseksi
DE4023134A DE4023134C2 (de) 1989-07-28 1990-07-20 Verfahren zur Herstellung einer pharmazeutischen Zubereitung in Form von Mikropartikeln
US07/555,973 US5134122A (en) 1989-07-28 1990-07-20 Method for preparing a pharmaceutical composition in the form of microparticles
FR909009333A FR2650182B1 (fr) 1989-07-28 1990-07-20 Procede de preparation d'une composition pharmaceutique sous forme de microparticules
ES9001976A ES2020890A6 (es) 1989-07-28 1990-07-23 Procedimiento de preparacion de una composicion farmaceutica en forma de microparticulas.
IT02101990A IT1243357B (it) 1989-07-28 1990-07-23 Metodo per preparare una composizione farmaceutica in forma di microparticelle
CA002021767A CA2021767C (en) 1989-07-28 1990-07-23 Method for preparing a pharmaceutical composition in the form of microparticles
NO903264A NO300304B1 (no) 1989-07-28 1990-07-23 Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av mikropartikler
AT0154590A AT397197B (de) 1989-07-28 1990-07-23 Verfahren zur herstellung einer pharmazeutischen zubereitung in form von mikropartikeln zur herstellung von injizierbaren suspensionen zur verzögerten und kontrollierten abgabe eines peptids
GR900100568A GR1001215B (el) 1989-07-28 1990-07-25 Μεθοδος για την παρασκευη μιας συνθεσης με την μορφη μικροσωματιδιων.
LU87772A LU87772A1 (fr) 1989-07-28 1990-07-25 Procede de preparation d'une composition pharmaceutique sous forme de microparticules
DK199001807A DK175495B1 (da) 1989-07-28 1990-07-27 Fremstilling af farmaceutisk præparat
PT94842A PT94842B (pt) 1989-07-28 1990-07-27 Processo para a preparacao de uma composicao farmaceutica sob a forma de microparticulas de um copolimero de acido lactico e glicolico e incorporando como substancia activa um pamoato, tanato, estearato ou palmitato de um peptido natural ou sintetico
JP2201063A JPH0662427B2 (ja) 1989-07-28 1990-07-27 微粒子状の薬剤組成物、その調製方法およびこの薬剤組成物より調製した懸濁剤
SE9002522A SE504279C2 (sv) 1989-07-28 1990-07-27 Metod för framställning av en farmaceutisk komposition i form av mikropartiklar innehållande peptider
US07/790,033 US5439688A (en) 1989-07-28 1991-11-12 Process for preparing a pharmaceutical composition
US07/836,478 US5225205A (en) 1989-07-28 1992-02-18 Pharmaceutical composition in the form of microparticles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2829/89A CH679207A5 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) 1989-07-28 1989-07-28

Publications (1)

Publication Number Publication Date
CH679207A5 true CH679207A5 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) 1992-01-15

Family

ID=4242536

Family Applications (1)

Application Number Title Priority Date Filing Date
CH2829/89A CH679207A5 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) 1989-07-28 1989-07-28

Country Status (23)

Country Link
US (1) US5134122A (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
JP (1) JPH0662427B2 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
AT (1) AT397197B (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
AU (1) AU619996B2 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
BE (1) BE1003093A3 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
CA (1) CA2021767C (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
CH (1) CH679207A5 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
DE (1) DE4023134C2 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
DK (1) DK175495B1 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
ES (1) ES2020890A6 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
FI (1) FI97688C (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
FR (1) FR2650182B1 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
GB (1) GB2234169B (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
GR (1) GR1001215B (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
IE (1) IE65397B1 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
IL (1) IL95120A (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
IT (1) IT1243357B (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
LU (1) LU87772A1 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
NL (1) NL194858C (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
NO (1) NO300304B1 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
PT (1) PT94842B (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
SE (1) SE504279C2 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
ZA (1) ZA905654B (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245346B1 (en) 1996-05-06 2001-06-12 Debio Recherche Pharmaceutique S.A. Pharmaceutical compositions for the sustained release of insoluble active principles
EP2630964A1 (en) 2012-02-22 2013-08-28 Immundiagnostik AG Method and medicament for treating patients in risk of prediabetes and type-2 diabetes
EP3431077A1 (en) 2007-06-06 2019-01-23 Debiopharm Research & Manufacturing SA Slow release pharmaceutical composition made of microparticles

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
PH30995A (en) * 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
CH681425A5 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) * 1990-11-14 1993-03-31 Debio Rech Pharma Sa
US6517859B1 (en) 1990-05-16 2003-02-11 Southern Research Institute Microcapsules for administration of neuroactive agents
ES2185615T3 (es) * 1990-05-16 2003-05-01 Southern Res Inst Uso y liberacion controlada de las microcapsulas para estimular el crecimiento de la fibra nerviosa.
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
WO1993015722A1 (en) * 1992-02-07 1993-08-19 Syntex (Usa) Inc. Controlled delivery of pharmaceuticals from preformed porous microparticles
US6013853A (en) * 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
US5876452A (en) * 1992-02-14 1999-03-02 Board Of Regents, University Of Texas System Biodegradable implant
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
US5456917A (en) * 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
DE4342092B4 (de) * 1993-12-09 2007-01-11 Zentaris Gmbh Langwirkende Injektionssuspension und Verfahren zur Herstellung
CA2178592C (en) * 1993-12-09 2009-07-28 Jurgen Engel Long-acting injection suspensions and a process for their preparation
US5417982A (en) * 1994-02-17 1995-05-23 Modi; Pankaj Controlled release of drugs or hormones in biodegradable polymer microspheres
US5569468A (en) * 1994-02-17 1996-10-29 Modi; Pankaj Vaccine delivery system for immunization, using biodegradable polymer microspheres
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
US5595760A (en) * 1994-09-02 1997-01-21 Delab Sustained release of peptides from pharmaceutical compositions
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
EP0930874A2 (en) * 1996-10-09 1999-07-28 Takeda Chemical Industries, Ltd. A method for producing a microparticle
WO1998032423A1 (en) * 1997-01-29 1998-07-30 Takeda Chemical Industries, Ltd. Sustained-release microspheres, their production and use
US6071982A (en) * 1997-04-18 2000-06-06 Cambridge Scientific, Inc. Bioerodible polymeric semi-interpenetrating network alloys for surgical plates and bone cements, and method for making same
AU1384199A (en) 1997-11-07 1999-05-31 Chiron Corporation Method for producing igf-1 sustained-release formulations
IT1304152B1 (it) * 1998-12-10 2001-03-08 Mediolanum Farmaceutici Srl Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
HK1041645B (zh) * 1998-12-16 2005-07-29 Aventisub Ii Inc. 生物可降解聚合物包封的5-羟色胺受体拮抗剂及其制备方法
US6455526B1 (en) 1998-12-16 2002-09-24 Aventis Pharmaceuticals, Inc. Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same
EP2286792A1 (en) 1999-02-26 2011-02-23 Novartis Vaccines and Diagnostics, Inc. Microemulsions with an adsorbent surface, comprising a microdroplet emulsion
US7713739B1 (en) 2000-11-17 2010-05-11 Novartis Vaccines And Diagnostics, Inc. Microparticle-based transfection and activation of dendritic cells
ES2169980B1 (es) 1999-12-17 2003-11-01 Lipotec Sa Microcapsulas para la liberacion prolongada de farmacos.
US6362308B1 (en) 2000-08-10 2002-03-26 Alkermes Controlled Therapeutics Inc. Ii Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
US20040022853A1 (en) * 2001-04-26 2004-02-05 Control Delivery Systems, Inc. Polymer-based, sustained release drug delivery system
EP1383504A1 (en) * 2001-04-26 2004-01-28 Control Delivery Systems, Inc. Sustained release drug delivery system containing codrugs
WO2002094226A1 (de) * 2001-05-23 2002-11-28 Hexal Ag Homogenisat für implantate und mikropartikel
JP2004535431A (ja) 2001-06-22 2004-11-25 サザン バイオシステムズ， インコーポレイテッド ゼロ次長期放出同軸インプラント
IN2014DN10834A (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) * 2001-09-17 2015-09-04 Psivida Inc
EP1532985B1 (en) * 2002-06-25 2016-10-12 Takeda Pharmaceutical Company Limited Process for producing a sustained-release composition
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
DE602004007105T2 (de) 2003-01-28 2008-02-28 Microbia Inc., Cambridge Zusammensetzung zur behandlung von gastrointestinalen störungen
GB0304726D0 (en) * 2003-03-01 2003-04-02 Ardana Bioscience Ltd New Process
KR20060033859A (ko) * 2003-04-30 2006-04-20 데비오 팜 소시에떼 아노님 생식선 자극 호르몬 방출 호르몬을 이용한 방법 및 조성물
WO2005020933A2 (en) * 2003-09-02 2005-03-10 University Of South Florida Nanoparticles for drug-delivery
JP5105578B2 (ja) 2003-11-05 2012-12-26 サーコード バイオサイエンス インコーポレイテッド 細胞接着のモジュレーター
WO2005063276A1 (en) * 2003-12-23 2005-07-14 Debiopharm S.A. Methods and compositions using gonadotropin hormone releasing hormone
FR2865938B1 (fr) 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
EP2594259A1 (en) 2004-08-04 2013-05-22 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
CA2578113A1 (en) 2004-08-30 2006-03-09 Spineovations, Inc. Method of treating spinal internal disk derangement
EP1674082A1 (de) * 2004-12-22 2006-06-28 Zentaris GmbH Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel
SI1881823T1 (sl) 2005-05-17 2015-04-30 Sarcode Bioscience Inc. Sestavki in postopki za zdravljenje bolezni oäśesa
KR100722607B1 (ko) * 2006-05-11 2007-05-28 주식회사 펩트론 분산성 및 주사 투여능이 향상된 서방성 미립구의 제조방법
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2393885T7 (es) 2007-06-04 2014-01-30 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
CA3105972A1 (en) * 2007-10-19 2009-04-30 Novartis Ag Compositions and methods for treatment of diabetic retinopathy
US8728528B2 (en) 2007-12-20 2014-05-20 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
US8469961B2 (en) * 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US20100010549A1 (en) * 2008-03-05 2010-01-14 Neville Alleyne device and method of minimally invasive extracapsular ligamentous augmentation for canine stifle ligament injuries
EP2276508A4 (en) * 2008-04-15 2011-12-28 Sarcode Bioscience Inc ADMINISTRATION OF LFA-1 ANTAGONISTS TO THE GASTROINTESTINAL SYSTEM
WO2009139817A2 (en) 2008-04-15 2009-11-19 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
EP2421517A4 (en) * 2009-04-23 2013-08-07 Sustained Nano Systems Llc DONATION DEVICE WITH CONTROLLED OUTPUT
US8378105B2 (en) 2009-10-21 2013-02-19 Sarcode Bioscience Inc. Crystalline pharmaceutical and methods of preparation and use thereof
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
KR101411349B1 (ko) 2010-12-24 2014-06-25 주식회사 삼양바이오팜 생리활성 펩타이드를 포함하는 마이크로입자 및 그의 제조방법, 및 그를 포함하는 약제학적 조성물
CA2835018C (en) 2011-05-04 2020-04-21 Balance Therapeutics, Inc. Pentylenetetrazole derivatives
PT2851085T (pt) * 2012-05-14 2019-10-11 Teijin Pharma Ltd Composição proteica esterilizada por radiação
WO2014018748A1 (en) 2012-07-25 2014-01-30 Sarcode Bioscience Inc. Lfa-1 inhibitor and polymorph thereof
AU2014218599C1 (en) 2013-02-25 2018-09-06 Bausch Health Ireland Limited Guanylate cyclase receptor agonists for use in colonic cleansing
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
WO2015052204A1 (en) * 2013-10-08 2015-04-16 Ferring Bv Microparticles comprising gnrh made by pgss
EP3054969B1 (en) 2013-10-10 2021-03-10 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of opioid induced dysfunctions
KR102024447B1 (ko) 2015-01-16 2019-11-14 스파인오베이션즈, 인크. 척추 디스크를 치료하기 위한 작용제 및 작용제를 포함하는 의료 키트
CA3009814A1 (en) 2016-01-11 2017-07-20 Synergy Pharmaceuticals, Inc. Formulations and methods for treating ulcerative colitis
BR112020000506A2 (pt) 2017-07-11 2020-07-14 Sustained Nano Systems Llc formulações farmacêuticas hipercomprimidas
EP3651771B1 (en) 2017-07-11 2023-08-30 Sustained Nano Systems LLC Radiation sterilization of hypercompressed polymer dosage forms
US11052046B2 (en) 2017-09-26 2021-07-06 Nanomi B.V. Method for preparing micro-particles by double emulsion technique
WO2021185373A1 (zh) * 2020-03-20 2021-09-23 苏州医本生命科技有限公司 载药用微粒、载药微粒、蓄粒管及其植入系统
US12318508B2 (en) 2023-06-02 2025-06-03 33 Medical, Inc. Compositions for treatment of discogenic pain, and processes for making and using the same

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3976071A (en) * 1974-01-07 1976-08-24 Dynatech Corporation Methods of improving control of release rates and products useful in same
US3978203A (en) * 1974-07-12 1976-08-31 Dynatech Corporation Sustained release of pharmaceuticals from polyester matrices
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4622244A (en) * 1979-09-04 1986-11-11 The Washington University Process for preparation of microcapsules
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
PH19942A (en) * 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
US4483807A (en) * 1981-01-27 1984-11-20 Japan Atomic Energy Research Institute Process for producing a slow release composite
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
CH661206A5 (fr) * 1983-09-23 1987-07-15 Debiopharm Sa Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes.
JPS60181029A (ja) * 1984-02-29 1985-09-14 Toyo Jozo Co Ltd 徐放性製剤の製法
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
IL79134A (en) * 1985-07-29 1991-06-10 American Cyanamid Co Continuous release peptide implants for parenteral administration
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
JPS63218632A (ja) * 1987-03-06 1988-09-12 Japan Atom Energy Res Inst ホルモンに徐放性機能を付与した生体分解型コポリ（グルコ−ル酸／ｌ−乳酸）複合体の製造方法
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
DE3734223A1 (de) * 1987-10-09 1989-04-20 Boehringer Ingelheim Kg Implantierbares, biologisch abbaubares wirkstofffreigabesystem

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245346B1 (en) 1996-05-06 2001-06-12 Debio Recherche Pharmaceutique S.A. Pharmaceutical compositions for the sustained release of insoluble active principles
EP3431077A1 (en) 2007-06-06 2019-01-23 Debiopharm Research & Manufacturing SA Slow release pharmaceutical composition made of microparticles
EP2630964A1 (en) 2012-02-22 2013-08-28 Immundiagnostik AG Method and medicament for treating patients in risk of prediabetes and type-2 diabetes

Also Published As

Publication number Publication date
IT9021019A0 (it) 1990-07-23
NL9001646A (nl) 1991-02-18
FR2650182A1 (fr) 1991-02-01
GB2234169A (en) 1991-01-30
AU619996B2 (en) 1992-02-06
NL194858C (nl) 2003-05-06
NO300304B1 (no) 1997-05-12
SE9002522D0 (sv) 1990-07-27
US5134122A (en) 1992-07-28
IE65397B1 (en) 1995-10-18
IL95120A0 (en) 1991-06-10
GR900100568A (en) 1991-12-10
NO903264D0 (no) 1990-07-23
PT94842B (pt) 1997-04-30
FI97688C (fi) 1997-02-10
FR2650182B1 (fr) 1992-05-15
JPH0366625A (ja) 1991-03-22
IT1243357B (it) 1994-06-10
GR1001215B (el) 1993-06-21
AU5910390A (en) 1991-01-31
CA2021767A1 (en) 1991-01-29
IE902592A1 (en) 1991-02-27
DE4023134A1 (de) 1991-01-31
DE4023134C2 (de) 1997-04-17
ZA905654B (en) 1991-05-29
FI903643A0 (fi) 1990-07-19
LU87772A1 (fr) 1990-12-11
IT9021019A1 (it) 1992-01-23
GB9015722D0 (en) 1990-09-05
SE504279C2 (sv) 1996-12-23
IL95120A (en) 1994-10-07
ATA154590A (de) 1993-07-15
DK180790D0 (da) 1990-07-27
GB2234169B (en) 1993-02-10
PT94842A (pt) 1991-03-20
FI97688B (fi) 1996-10-31
DK180790A (da) 1991-01-29
ES2020890A6 (es) 1991-10-01
JPH0662427B2 (ja) 1994-08-17
NO903264L (no) 1991-01-29
AT397197B (de) 1994-02-25
NL194858B (nl) 2003-01-06
DK175495B1 (da) 2004-11-08
SE9002522L (sv) 1991-01-29
BE1003093A3 (fr) 1991-11-19
CA2021767C (en) 1996-10-22

Similar Documents

Publication Publication Date Title
CH679207A5 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html)
US5439688A (en) Process for preparing a pharmaceutical composition
DE69032976T2 (de) Zubereitung von pharmazeutischen und anderen matrixsystemen durch auflösung in festem zustand
US4371516A (en) Articles for carrying chemicals
EP0735860B1 (fr) Nouvelles compositions pour mousses, notamment mousses rectales, et mousses ainsi obtenues
EP0621777B1 (de) Wirkstoff-enthaltende festkörper mit einem gerüst aus hydrophilen makromolekülen und verfahren zu ihrer herstellung
HU188234B (en) Method for producing solid shaped product
IL105553A (en) Solid dosage form comprising a porous network of matrix forming material which disperses rapidly in water
DE69212503T2 (de) Verfahren zur herstellung von porösen abgabevorrichtungen
JP2000505801A (ja) トレハロースを含む固形製剤
JP2022521319A (ja) インライン混合中の懸濁液の通気の最小化
NL8802274A (nl) Zetpillen.
EP0440702B1 (en) A pharmaceutical composition for rapid release of the active component comprising a solid dispersion and a surfactant
BE1004923A5 (fr) Procede de preparation d'une composition pharmaceutique.
HUE033660T2 (en) Spray containing fine particulate active ingredient
FR2748205A1 (fr) Compositions pharmaceutiques pour la liberation controlee de principes actifs insolubles
CH685285A5 (fr) Procédé de préparation d'une composition pharmaceutique contenant des sels de peptides.
Ford et al. The effect of particle size on some in-vitro and in-vivo properties of indomethacin-polyethylene glycol 6000 solid dispersions
JPH0278613A (ja) 精油含有軟カプセル
CA2247877A1 (en) Solubilizing delivery systems and method of manufacture
AU2002244857B2 (en) Pharmaceutical product with reticulated crystalline microstructure
AU677198C (en) Pharmaceutical and other dosage forms

Legal Events

Date Code Title Description
PUE Assignment

Owner name: DEBIO RECHERCHE PHARMACEUTIQUE S.A.

PL Patent ceased